Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754442 · ClinicalTrials.gov registry record · NA
Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00754442 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 20 participants.
The verdict
NCT00754442, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a reduction in the enzyme 1-hydroxylase, which activates Vitamin D, is the cause of overactivity of the parathyroid glands (called secondary hyperparathyroidism - normal blood calcium and elevated parathyroid hormone) in a selected group of young patients with normal kidney function.
Interventions
- DRUG Teriparatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754442
The ClinicalTrials.gov registry entry for NCT00754442 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Teriparatide is the first listed.
NCT00754442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00754442 about?
NCT00754442 is a clinical study titled "Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism". The purpose of this study is to determine if a reduction in the enzyme 1-hydroxylase, which activates Vitamin D, is the cause of overactivity of the parathyroid glands (called secondary hyperparathyroidism - normal blood calcium and elevated parathyroid hormone) in a selected group of young patients...
What is the current status of trial NCT00754442?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-02. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00754442?
The interventions under investigation include: Teriparatide (DRUG).
Who is sponsoring clinical trial NCT00754442?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.